pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioPharma Dive·Jul 30·1 min read
save

FTC Sues Hims & Hers for Alleged Illegal Sharing of Patient Data and Deceptive Billing

Jul 30, 2026·read at BioPharma Dive ↗RegulatoryNegative

The Federal Trade Commission has filed a lawsuit against Hims & Hers, a California‑based telehealth company, accusing it of violating privacy laws.

The complaint says the firm used tracking pixels on its website that sent patients' health information to third‑party advertising platforms such as Meta and Snap without consent.

The agency also alleges Hims & Hers made it hard for users to cancel subscriptions and billed patients for prescription medications before they had a consultation with a provider.

Hims & Hers called the claims “baseless,” saying the FTC is misinterpreting the law.

source

This writeup was produced by pharmadog from original reporting by BioPharma Dive.

Original headline: “FTC sues Hims & Hers over alleged privacy violations, deceptive billing practices”

read at BioPharma Dive ↗
694 words · retrieved Jul 30
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
NEXUS
topics
Obesity

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: RegCell wrangles $66M; Encoded finagles $275M series FFierce Biotech
  • Apr 30STAT+: New obesity tool aims to predict risk of 18 serious complicationsSTAT
  • Apr 29STAT+: A patent win for Pfizer and BridgeBioSTAT
  • Apr 28STAT+: FDA launches effort to speed up clinical trials, using AISTAT
  • Apr 28Fauci adviser David Morens indicted on charges of concealing emails, avoiding records requestsSTAT